The global market for hemostatic products, including hemostatic powder, is experiencing robust growth, driven by the increasing number of surgical procedures, the rising prevalence of chronic diseases and advancements in medical technology. As of 2025, research suggests the hemostasis products market was valued at USD 1.75 billion in 2024 and is projected to reach USD 2.97 billion by 2034, growing at a CAGR of 5.47%. Another report estimates the global hemostats market size to grow from $5.09 billion in 2024 to $9.33 billion by 2032, at a CAGR of 8.1%. This expansion presents significant opportunities for distributors of hemostatic powder, a critical component in managing surgical bleeding and enhancing patient outcomes.
Understanding Bleeding Stop Power
Hemostatic powder, also known as hemostatic powder, is a topical agent applied during surgeries to rapidly stop bleeding by promoting clotting. It is particularly valuable in complex procedures where traditional methods like suturing or cauterization may be less effective, such as in cardiovascular, hepatobiliary, and thoracic surgeries. Surgiclean, a leader in absorbable biomaterials established in 2003, offers innovative hemostatic powder that is 100% plant-based, biocompatible, and fully absorbed by the body within 14 days. The hemostatic powder by Surgiclean is designed for use across various surgical specialties, making them a versatile solution for healthcare professionals.
Market Drivers and Growth Projections for Hemostatic powder
Several factors are fueling the growth of hemostatic products market, particularly for hemostatic powder:
Increasing Surgical Procedures
The global rise in surgeries is driven by an aging population and the increasing prevalence of chronic diseases such as cardiovascular diseases and liver diseases. According to the World Health Organization (WHO), over 1.25 million people are injured in road accidents annually, many resulting in severe bleeding, further increasing the need for hemostatic powder.
Shift to Minimally Invasive Surgeries
The growing preference for minimally invasive procedures increases the demand for advanced hemostatic powder that can control bleeding with minimal tissue damage, reducing recovery time and complications.
Rising Healthcare Expenditure
Increased investment in healthcare infrastructure, especially in emerging economies, is boosting the demand for advanced medical products such as hemostatic powder. The Asia-Pacific region, for example, is expected to witness the highest growth rate due to factors like increased healthcare spending and modernization.
Market projections indicate a steady growth trajectory. The hemostasis products market is expected to grow at a CAGR of 5.47% from 2025 to 2034, while the hemostats market is anticipated to achieve a CAGR of 8.1% by 2032. These figures highlight the expanding opportunity for distributors to meet global demand.
Regional Insights for hemostatic powder
|
Region |
2024 Market Share |
Projected CAGR (2025-2034) |
Key Drivers |
|
North America |
32.62% |
5.2% |
High medical expenditure, tech adoption |
|
Europe |
25% |
5.5% |
Regulatory compliance, aging population |
|
Asia-Pacific |
20% |
6.0% |
Medical infrastructure expansion, income growth |
|
Latin America |
15% |
5.8% |
Improved medical access, chronic diseases |
|
Middle East & Africa |
7.38% |
5.3% |
Investment growth, rising surgery volumes |
Opportunities for Distributors
Distributors of hemostatic products, particularly hemostatic powder, are well-positioned to capitalize on this growth in 2025. Key opportunities include:
Expanding Market Reach
With the global hemostatic products market expected to grow, distributors can expand into new regions, especially emerging markets where healthcare infrastructure is rapidly improving.
Partnering with Innovative Companies
Collaborating with companies like Surgiclean, which invests heavily in R&D and holds numerous patents, can provide distributors with cutting-edge products that meet the evolving needs of the market. Surgiclean's global presence, with registration in over 50 countries and sales channels covering more than 120 countries, makes it an attractive partner.
Leveraging Digital Plarforms
Utilizing digital marketing and e-commerce platforms can help distributors reach a wider audience, streamline operation and increase sales efficiency, especially in markets with high digital penetration.
Surgiclean's Role in the Market
Surgiclean is a key player in the hemostatic products market, with a strong focus on innovation and quality. The company's commitment to R&D is evident in its investment of over 10% of annual revenue into research, resulting in 46 patents and a state-of-the-art manufacturing facility. Surgiclean's hemostatic powder is made from potato starch, ensuring the powder is 100% plant-based and free from animal-derived components, enhancing biocompatibility and safety.
Surgiclean's global footprint, with 30+ CE certificates and sales in 120+ countries, positions it as a reliable partner for distributors seeking high-quality, innovative hemostatic powder. Customer feedback from surgeons worldwide highlights the product's effectiveness, with gel formation in approximately 60 seconds and hemostasis achieved in about 3 minutes.
Ready to partner with Surgiclean?
Partner with Surgiclean to bring high-performance hemostatic powder to your customers. Join our global distribution network and expand your medical product offerings with proven, CE-certified solutions.